| CHRNA5 |
NACHRA5, CHRNA5: Neuronal acetylcholine receptor subunit alpha-5 precursor |
CHRNA6 |
CHRNA6: Neuronal acetylcholine receptor subunit alpha-6 precursor |
0.575 |
Evidence |
|
| CD1C |
CD1C: T-cell surface glycoprotein CD1c precursor |
HLA-DRB5 |
HLA-Dw12: Cell surface glycoprotein |
0.575 |
Evidence |
|
| CD1C |
CD1C: T-cell surface glycoprotein CD1c precursor |
HLA-DMA |
DMA, HLA-DMA, DAQB-96B10.1-001, DASS-67H14.8-001, XXbac-BCX136A3.1-001, XXbac-BP |
0.575 |
Evidence |
|
| CD1C |
CD1C: T-cell surface glycoprotein CD1c precursor |
HLA-DRB5 |
HLA-DRB3: HLA class II histocompatibility antigen, DRB3-1 beta chain precursor |
0.575 |
Evidence |
|
| ZNF42 |
MZF1, MZF, ZNF42, ZSCAN6: Myeloid zinc finger 1 |
ZNF266 |
ZNF266, KIAA2007: Zinc finger protein 266 |
0.575 |
Evidence |
|
| PSMB6 |
PSMB6, LMPY: Proteasome subunit beta type-6 precursor |
CTRL |
PSMB10, MECL1: Proteasome subunit beta type-10 precursor |
0.575 |
Evidence |
|
| HLA-DMB |
HLA-DMB, DMB, RING7: HLA class II histocompatibility antigen, DM beta chain prec |
MICB |
MICB: MHC class I polypeptide-related sequence B (Fragment) |
0.575 |
Evidence |
|
| HLA-DMB |
HLA-DMB, DMB, RING7: HLA class II histocompatibility antigen, DM beta chain prec |
FCGRT |
FCGRT, FCRN: IgG receptor FcRn large subunit p51 precursor |
0.575 |
Evidence |
|
| HLA-DMB |
HLA-DMB, DMB, RING7: HLA class II histocompatibility antigen, DM beta chain prec |
CD1C |
CD1C: T-cell surface glycoprotein CD1c precursor |
0.575 |
Evidence |
|
| TNFRSF7 |
CD27, TNFRSF7: CD27 antigen precursor |
TNFSF7 |
CD70, CD27L, CD27LG, TNFSF7: CD70 antigen |
0.575 |
Evidence |
|
| PSMA2 |
PSMA2, PSC3: Proteasome subunit alpha type-2 |
CTRL |
PSMB10, MECL1: Proteasome subunit beta type-10 precursor |
0.575 |
Evidence |
O
|
| GABRR1 |
IPI00027150 |
HTR3A |
5-hydroxytryptamine |
0.575 |
Evidence |
|
| GABRR1 |
IPI00027150 |
CHRNA5 |
NACHRA5, CHRNA5: Neuronal acetylcholine receptor subunit alpha-5 precursor |
0.575 |
Evidence |
|
| GLRA1 |
IPI00011565 |
HTR3A |
5-hydroxytryptamine |
0.575 |
Evidence |
|
| GZMH |
GZMH, CGL2, CTSGL2: Granzyme H precursor |
SERPINB9 |
SERPINB9, PI9: Serpin B9 |
0.575 |
Evidence |
|
| CHRM3 |
CHRM3: Muscarinic acetylcholine receptor M3 |
GNAO1 |
GNAO1: Guanine nucleotide-binding protein G(o) subunit alpha 2 |
0.575 |
Evidence |
|
| HLA-DPA1 |
HLA-DPA1, HLA-DP1A, HLASB: HLA class II histocompatibility antigen, DP alpha cha |
CD1C |
CD1C: T-cell surface glycoprotein CD1c precursor |
0.575 |
Evidence |
|
| TFEB |
TFEB: Transcription factor EB |
MNT |
MNT, ROX: Max-binding protein MNT |
0.575 |
Evidence |
|
| GNAZ |
GNAZ: Guanine nucleotide-binding protein G(z) subunit alpha |
OMG |
OMG, OMGP: Oligodendrocyte-myelin glycoprotein precursor |
0.575 |
Evidence |
|
| CTRB1 |
CTRB1, CTRB: Chymotrypsinogen B precursor |
SERPINA3 |
IPI00550991 |
0.575 |
Evidence |
|
| ZNF24 |
ZNF24, KOX17, ZNF191, ZSCAN3: Zinc finger protein 24 |
POGK |
POGK, KIAA1513, LST003, SLTP003: Pogo transposable element with KRAB domain |
0.575 |
Evidence |
|
| POR |
POR, CYPOR: NADPH--cytochrome P450 reductase |
CYP2D6 |
CYP2D6, CYP2DL1: Cytochrome P450 2D6 |
0.575 |
Evidence |
|
| CD1D |
CD1D: T-cell surface glycoprotein CD1d precursor |
HLA-DMA |
DMA, HLA-DMA, DAQB-96B10.1-001, DASS-67H14.8-001, XXbac-BCX136A3.1-001, XXbac-BP |
0.575 |
Evidence |
|
| CD1D |
CD1D: T-cell surface glycoprotein CD1d precursor |
HLA-DRB5 |
HLA-DRB3: HLA class II histocompatibility antigen, DRB3-1 beta chain precursor |
0.575 |
Evidence |
|
| CD1D |
CD1D: T-cell surface glycoprotein CD1d precursor |
B2M |
B2M, CDABP0092, HDCMA22P: Beta-2-microglobulin precursor [Contains: Beta-2-micro |
0.575 |
Evidence |
O
|